How is dilated cardiomyopathy investigated in Scotland? A contemporary survey
Robin A P Weir1, Joanne Simpson, Colin J Petrie
1Consultant Cardiologist, Cardiology Department, Hairmyres Hospital, Lanarkshire, Scotland, UK.
Insights
Dilated cardiomyopathy (DCM) investigations in Scotland fall short of European Society of Cardiology (ESC) guidelines. Many Scottish hospitals do not routinely perform recommended diagnostic tests for DCM aetiology.
Area of Science:
- Cardiology
- Heart Failure Research
- Diagnostic Imaging
Background:
- Dilated cardiomyopathy (DCM) is a frequent cause of heart failure.
- Approximately 50% of DCM cases are classified as idiopathic due to poorly characterized aetiology.
- Current diagnostic practices for DCM in Scotland are compared against European Society of Cardiology (ESC) recommendations.
Purpose of the Study:
- To assess the extent of DCM aetiology investigation in Scotland.
- To compare current practices with ESC guidelines for DCM diagnosis.
Main Methods:
- Surveys were distributed to cardiology departments in 23 Scottish hospitals.
- Investigated were the use and availability of coronary angiography, cardiac magnetic resonance imaging (CMR), and blood/urine panels.
- Response rate was 91.3% (21/23 hospitals).
Main Results:
- Only 38.1% of responding hospitals adopted ESC guidelines for coronary angiography.
- Easy access to CMR was available in only 33.3% of centers.
- Routine use of the ESC-recommended blood profile for DCM was reported by 33.3% of hospitals.
Conclusions:
- DCM patients in Scotland generally do not undergo the full spectrum of ESC-recommended etiological investigations.
- Further prospective studies are needed to evaluate the efficacy and impact of comprehensive DCM diagnostic approaches on patient management and outcomes.
Background And Aims:
Dilated cardiomyopathy (DCM) is a common cause of heart failure. The underlying aetiology remains poorly characterised, with ca. 50% labelled 'idiopathic'. We assessed the extent to which the aetiology of DCM is investigated in Scotland, in comparison to European Society of Cardiology (ESC) recommendations.
Methods And Results:
Questionnaires regarding the use of coronary angiography, use and availability of cardiac magnetic resonance imaging (CMR) and blood/urine panels to investigate the causes of DCM were sent to the heart failure lead in each of the 23 hospitals across Scotland with an established cardiology department; responses were obtained from 21/23 (91.3%). ESC guidelines regarding coronary angiography were adopted in only 8/21 (38.1%). Only 7/21 (33.3%) had easy access to CMR although 14/21 (66.7%) felt it would be a useful test in DCM. The ESC-recommended blood profile was checked routinely in 7/21 (33.3%). Additional blood tests, many of which not currently recommended, were performed in selected centres.
Conclusions:
DCM patients in Scotland are in general unlikely to undergo current ESC-recommended investigation into the underlying aetiology. There is a need for prospective studies to determine the success rate and influence on management and outcome of such multifaceted approaches to investigating the cause of DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies


